Intra-amniotic Candida albicans Infection Treated With Liposomal Amphotericin B With a Successful Neonatal Outcome

Open Forum Infect Dis. 2024 Jan 31;11(2):ofae047. doi: 10.1093/ofid/ofae047. eCollection 2024 Feb.

Abstract

Intra-amniotic infection with Candida species is an uncommon but severe condition with high fetal morbimortality and no established clinical guidelines for its management. We report a Candida albicans intra-amniotic infection diagnosed in a 25-week pregnant woman, successfully treated with high-dose liposomal amphotericin B. Pregnancy was prolonged until 30 weeks, and despite persistently positive Candida cultures in amniotic fluid, a healthy newborn was delivered without evidence of systemic infection. Amphotericin concentration was determined at birth, revealing levels over 30 times higher in mother's and cord blood than in the amniotic fluid, probably explaining the clinical protection despite failure in obtaining fungal clearance.

Keywords: Candida albicans; cervical insufficiency; chorioamnionitis; fungal chorioamnionitis; intra-amniotic infection; liposomal amphotericin B.

Publication types

  • Case Reports